Oklahoma 2024 Regular Session

Oklahoma House Bill HB2512 Latest Draft

Bill / Introduced Version Filed 01/19/2023

                             
 
Req. No. 7041 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
1st Session of the 59th Legislature (2023) 
 
HOUSE BILL 2512 	By: Pittman 
 
 
 
 
 
AS INTRODUCED 
 
An Act relating to public health and safety; defining 
terms; providing screening for chronic kidney disease 
for certain individuals; providing for exceptions; 
creating rules for health care pro viders if diagnoses 
is positive; providing for codification; and 
providing an effective date. 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     NEW LAW    A new section of law to be codified 
in the Oklahoma Statu tes as Section 1-2603.10 of Title 63, unless 
there is created a duplication in numbering, reads as follows: 
The following words and phrases , when used in this section, 
shall have the meanings unle ss the context clearly indicates 
otherwise: 
1.  "Chronic kidney disease" means an estimated glomerular 
filtration rate (eGFR)<60 ml/min/1.73m2 and/or markers of kidney 
damage for at least three months ; 
2. "Department" means the Oklahoma State Department of Health; 
3. "Health care facility " means any nonfederal institution, 
building, or agency or portion thereof, whether public or private or   
 
Req. No. 7041 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
for profit or nonprofit, that is used, operated, or designed to 
provide health services, medical treatment, or nursi ng, 
rehabilitative, or preventive care to any person or perso ns.  This 
includes, but is not limited to: ambulatory surgical facilities, 
hospitals, infirmaries, intermediat e care facilities, kidney 
dialysis centers, long -term care facilities, mental health centers, 
outpatient facilities, public health centers, rehabi litation 
facilities, residential treatments facilities, skilled nursing 
facilities, special care facilities, m edical laboratories, and adult 
day-care centers.  This also includes, but is not limi ted to, the 
following related property when used for or in co nnection with the 
foregoing: laboratories; research facilities; pharmacies; laundry 
facilities; health personne l training and lodging facilities; 
patient, guest, and health personnel food service facilities; and 
offices and office buildings for persons eng aged in health care 
professions or service s; 
4. "Health care practitioner" means a physician, nurse 
practitioner, or physician assistant who has prescriptive authority 
and is licensed to practice in the State of Oklahoma ; 
5. "Health care provider" means any person or entity who 
provides health care services incl uding, but not limited to, 
physicians, pharmacists, dentists, physician assistants, nurse 
practitioners, registered and other nurses, pa ramedics, emergency   
 
Req. No. 7041 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
medical or laboratory technicians, and am bulance and emergency 
medical workers; 
6. "Hospital" means any institution, place, building or agency, 
public or private, whether organized for profit or not, primarily 
engaged in the maintenanc e and operation of facilities for the 
diagnosis, treatment or care of patients admitted for overnight stay 
or longer in order to obtai n medical care, surgical care, 
obstetrical care, or nursing care for illness, disease, injury, 
infirmity, or deformity ; 
7. "Physician" means a physician licensed by and in good 
standing with the State Board of Medical Licensure and Supervision, 
the State Board of Osteopathic Examiners or the Board of Podiatr ic 
Medical Examiners; and 
8. "Screening test for chronic kidney dis ease" means any 
laboratory test that dete cts glomerular filtration rate estimated 
from the serum creatinine concentration (eGFR) using the C KD-EPI 
(CKD Epidemiology Collaboration) equation and albuminuria from the 
urinary albumin-creatinine ratio. 
SECTION 2.     NEW LAW     A new section of law to be codified 
in the Oklahoma Statutes as Section 1-2603.11 of Title 63, unless 
there is created a duplication in numbering, reads as follows: 
A. Each individual who, in the reasonable judgment of a 
treating health care practitioner, is at risk for chronic ki dney 
disease, including individuals with diab etes, hypertension,   
 
Req. No. 7041 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
cardiovascular disease, acute kidney injury, family history of 
kidney disease or who are older than sixty (60) years of age, who 
receives health services as an inpatient in a hospital or who 
receives primary care services in an outpatient department of a 
hospital, health care fa cility or physician's office, shall be 
offered a screening test for chronic kidney disease unless the 
health care practitioner reasonably believes at least one of the 
following: 
1. The individual is being treat ed for a life-threatening 
emergency; 
2. The individual has previously been offered or has been the 
subject of a screening test for chronic kidney disea se within the 
past year; or 
3. The individual lacks capacity to consent to a screening test 
for chronic kidney disease . 
B. If an individual accepts the offer of a screening test for 
chronic kidney disease and is diagnosed with chronic kidney disease, 
the health care provider shall: 
1. Either offer the individual follow-up health care or refer 
the individual to a health care provider who can provi de follow-up 
health care for individuals diagn osed with chronic kidney disease; 
and 
2. Provide the individual with information about chronic kidney 
disease, either verbal ly or in writing or by any other means at the   
 
Req. No. 7041 	Page 5  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
discretion of the health care provider, including without limitation 
information about the availability of genetic testing for the 
apolipoprotein L1 gene risk variant, and the meaning of the results 
of such test for individuals diagnosed with chronic kidney disease. 
3. The offering of chronic kidney disease screening test s under 
these sections shall be culturally and linguistically appropriate in 
accordance with regulations promulgated by the Department. 
4. This section shall not affect the scope of practice of any 
health care practitioner or diminish any authority or legal or 
professional obligation of any health care practitioner to offer a 
screening test for chronic kidney disease or to provide services or 
care for the subject of such a screening test. 
5. A health care provider or health care prac titioner that 
fails to comply with the requi rements of this section shall not be 
subject to any discipl inary actions related to their licensure or 
certification, or to any civil or criminal liability . 
SECTION 3.  This act shall become effective November 1, 2023. 
 
59-1-7041 TJ 12/19/22